2.81
price up icon17.08%   0.41
after-market Handel nachbörslich: 2.88 0.07 +2.49%
loading
Schlusskurs vom Vortag:
$2.40
Offen:
$2.49
24-Stunden-Volumen:
1.47M
Relative Volume:
1.71
Marktkapitalisierung:
$202.14M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-2.5315
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
+11.95%
1M Leistung:
+24.89%
6M Leistung:
-43.80%
1J Leistung:
-2.77%
1-Tages-Spanne:
Value
$2.47
$2.85
1-Wochen-Bereich:
Value
$2.32
$2.85
52-Wochen-Spanne:
Value
$1.90
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
Firmenname
Codexis Inc
Name
Telefon
650-421-8100
Name
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Mitarbeiter
188
Name
Twitter
@codexisinc
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
CDXS's Discussions on Twitter

Vergleichen Sie CDXS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CDXS
Codexis Inc
2.81 202.14M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-19 Herabstufung The Benchmark Company Buy → Hold
2024-06-03 Fortgesetzt Jefferies Buy
2024-05-30 Eingeleitet Cantor Fitzgerald Overweight
2024-02-29 Hochstufung The Benchmark Company Hold → Buy
2023-11-07 Herabstufung The Benchmark Company Buy → Hold
2023-08-07 Herabstufung TD Cowen Outperform → Market Perform
2023-05-09 Herabstufung H.C. Wainwright Buy → Neutral
2022-03-31 Fortgesetzt Piper Sandler Overweight
2022-03-02 Fortgesetzt Cowen Outperform
2021-04-12 Eingeleitet Piper Sandler Overweight
2021-03-01 Eingeleitet Stifel Buy
2021-02-26 Bestätigt H.C. Wainwright Buy
2020-03-10 Eingeleitet The Benchmark Company Buy
2019-01-17 Hochstufung First Analysis Sec Neutral → Outperform
2018-05-16 Eingeleitet Stephens Overweight
2017-10-13 Bestätigt H.C. Wainwright Buy
2017-05-31 Eingeleitet Jefferies Buy
2017-01-26 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-01-04 Hochstufung Ladenburg Thalmann Neutral → Buy
2016-01-06 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Codexis Inc Aktie (CDXS) Neueste Nachrichten

pulisher
Jun 18, 2025

Synthetic Biology Market Key Players AnalysisBota - openPR.com

Jun 18, 2025
pulisher
Jun 18, 2025

Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World

Jun 18, 2025
pulisher
Jun 16, 2025

Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks

Jun 16, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 05, 2025

Two Sigma Investments LP Buys 6,397 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Codexis at Jefferies Global Healthcare Conference: Enzymatic Synthesis Insights By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Has $127,000 Stake in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Raises Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $218,000 Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io

Jun 01, 2025
pulisher
May 28, 2025

Opaleye Management Makes a Bold Move with Massive Codexis Stock Purchase - TipRanks

May 28, 2025
pulisher
May 25, 2025

Group One Trading LLC Buys Shares of 15,226 Codexis, Inc. (NASDAQ:CDXS) - Defense World

May 25, 2025
pulisher
May 24, 2025

Codexis, Inc. (NASDAQ:CDXS) Stake Lifted by Northern Trust Corp - Defense World

May 24, 2025
pulisher
May 22, 2025

Codexis’ Landmark Presentations at TIDES USA Highlight - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Transcript : Codexis, Inc.Special Call - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Codexis (CDXS) Showcases Innovations in siRNA Manufacturing at T - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Codexis (CDXS) Showcases Innovations in siRNA Manufacturing at TIDES USA | CDXS Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Codexis Highlights Advancements in Eco Synthesis Technology for siRNA Manufacturing at TIDES USA Conference - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process ... - Bluefield Daily Telegraph

May 22, 2025
pulisher
May 22, 2025

Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewswire Inc.

May 22, 2025
pulisher
May 22, 2025

Codexis to Participate in Jefferies Global Healthcare Conference - The Manila Times

May 22, 2025
pulisher
May 21, 2025

Codexis to Participate in Jefferies Global Healthcare Conference | CDXS Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Argan Strengthens Board with Energy Giant Sempra Executive: Strategic Growth Move - Stock Titan

May 21, 2025
pulisher
May 21, 2025

Codexis’s SWOT analysis: innovative enzyme firm’s stock poised for growth - Investing.com Australia

May 21, 2025
pulisher
May 20, 2025

Codexis’s SWOT analysis: innovative enzyme firm’s stock poised for growth By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Former Genentech and Codexis Legal Leader Takes Top Legal Role at Liver Disease Biotech Aligos - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Codexis, Inc. (NASDAQ:CDXS) Shares Bought by Ameriprise Financial Inc. - Defense World

May 19, 2025
pulisher
May 19, 2025

Cantor Fitzgerald Lowers Earnings Estimates for Codexis - Defense World

May 19, 2025
pulisher
May 18, 2025

Codexis (NASDAQ:CDXS) Stock Rating Upgraded by StockNews.com - Defense World

May 18, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

May 18, 2025
pulisher
May 17, 2025

Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance

May 17, 2025
pulisher
May 17, 2025

Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st

May 17, 2025
pulisher
May 16, 2025

Codexis, Inc. (NASDAQ:CDXS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025
pulisher
May 16, 2025

Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Stifel Financial Corp - Defense World

May 16, 2025
pulisher
May 15, 2025

Codexis Earnings Call: Strategic Growth Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Codexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOs - MSN

May 15, 2025
pulisher
May 15, 2025

Stifel maintains Buy rating on Codexis stock with $5 target By Investing.com - Investing.com India

May 15, 2025
pulisher
May 15, 2025

Stifel maintains Buy rating on Codexis stock with $5 target - Investing.com

May 15, 2025
pulisher
May 15, 2025

Codexis May 2025 presentation slides: RNA manufacturing pivot targets path to profitability - Investing.com Canada

May 15, 2025
pulisher
May 15, 2025

Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with Strategic Growth Initiatives - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Codexis Inc (CDXS) Q1 2025 Earnings: EPS at -$0.23 and Revenue H - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with ... - Yahoo Finance

May 15, 2025
pulisher
May 14, 2025

Codexis Reports Q1 2025 Financial Results and Strategic Progress - TipRanks

May 14, 2025
pulisher
May 14, 2025

Codexis: Q1 Earnings Snapshot - MySA

May 14, 2025
pulisher
May 14, 2025

Earnings call transcript: Codexis Q1 2025 results miss forecasts, stock declines - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Codexis (CDXS) Navigates Q1 Revenue Challenges, Confirms 2025 Ou - GuruFocus

May 14, 2025

Finanzdaten der Codexis Inc-Aktie (CDXS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Codexis Inc-Aktie (CDXS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Opaleye Management Inc.
10% Owner
Jun 13 '25
Buy
2.23
99,102
220,997
12,199,102
Opaleye Management Inc.
10% Owner
Jun 16 '25
Buy
2.24
50,898
114,012
12,250,000
Opaleye Management Inc.
10% Owner
May 23 '25
Buy
2.36
2,320,000
5,475,200
11,995,000
Opaleye Management Inc.
10% Owner
May 28 '25
Buy
2.36
5,000
11,800
12,000,000
Opaleye Management Inc.
10% Owner
Apr 30 '25
Buy
2.31
25,000
57,660
9,655,000
Opaleye Management Inc.
10% Owner
May 01 '25
Buy
2.32
20,000
46,436
9,675,000
Opaleye Management Inc.
10% Owner
Apr 25 '25
Buy
2.24
25,000
55,915
9,630,000
Opaleye Management Inc.
10% Owner
Apr 16 '25
Buy
2.13
70,000
148,890
9,560,000
Opaleye Management Inc.
10% Owner
Apr 17 '25
Buy
2.09
45,000
94,162
9,605,000
Opaleye Management Inc.
10% Owner
Apr 15 '25
Buy
2.23
25,000
55,720
9,490,000
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):